18 employees
Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.
2019
$4.5M
from 2 investors over 2 rounds
Lassogen, Inc. raised $4.5M on October 13, 2020
Investors: Foothill Ventures and Playground Global